|
CY2019004I1
(en)
|
|
MODIFIED ANTI-IL-23P19 ANTIBODIES
|
|
DK2225280T3
(en)
|
|
BIVALENT, BISPECIFIC ANTIBODIES
|
|
BRPI0821375A2
(en)
|
|
Bispecific, bivalent antibodies
|
|
BRPI0821405A2
(en)
|
|
Bispecific, bivalent antibodies
|
|
BRPI0907237A2
(en)
|
|
Anti-cldn6 antibody
|
|
BRPI0819165A2
(en)
|
|
Anti-vegf Antibodies
|
|
BRPI0923231A2
(en)
|
|
anti-cmet antibody.
|
|
DK2131860T3
(en)
|
|
ANTI-sclerostin ANTIBODIES
|
|
BRPI0906877A2
(en)
|
|
Improved anti-trkb antibodies
|
|
BRPI0907532A2
(en)
|
|
Humanized anti-c5ar antibodies
|
|
SMT201700083B
(en)
|
|
MONOCLONAL ANTIBODIES
|
|
BRPI0922800A2
(en)
|
|
c-met antibodies
|
|
BRPI0807991A2
(en)
|
|
PREPARED ANTI-IL-23R ANTIBODIES.
|
|
BRPI0809677A2
(en)
|
|
Anti-GSE Antibodies
|
|
NO344963B1
(en)
|
|
Humanized antibody
|
|
DK2059533T3
(en)
|
|
MULTI-SPECIFIC ANTIBODIES
|
|
BRPI0923359A2
(en)
|
|
Anti-igf Antibodies
|
|
DK2234600T3
(en)
|
|
ANTIBODY FORMULATION
|
|
DK3072906T3
(en)
|
|
Antibody formulation
|
|
IL206161A0
(en)
|
|
Bivalent, bispecific antibodies
|
|
DK2651436T3
(en)
|
|
MYCOBACTERY ANTIGEN COMPOSITION.
|
|
DK2167128T3
(en)
|
|
MANUFACTURED ANTI-ALFA-V-INTEGRIN HYBRID ANTIBODIES
|
|
BRPI0817427A2
(en)
|
|
Anti-bst2 antibody
|
|
BRPI0814111A2
(en)
|
|
CYTOTOXIC MONOCLONAL ANTIBODY
|
|
BRPI0909633A2
(en)
|
|
anti-tyrp1 antibodies
|